Due to stronger sales at its pharmacy locations in the United States and the United Kingdom, Walgreens Boots Alliance announced a 68 % increase in fourth-quarter profit on Thursday, as COVID-19 limitations were loosened in the quarter.
As Delta variant instances increased throughout the quarter, Walgreens, one of the major U.S. pharmacies, saw an increase in sales from delivering COVID-19 vaccines and booster shots.
Before the bell, the company's stock was up 2.4 %.
Walgreens has given out more than 40 million COVID-19 vaccines as of Aug. 31, out of a total of 370.2 million doses given out in the United States.
In the fourth quarter, same-store sales at its U.S. pharmacies increased by 8.8% as it filled 313 million prescriptions.
For the quarter ended Aug. 31, net income attributable to the firm was $627 million, or 72 cents per share, compared to $373 million, or 43 cents per share, a year earlier.
Revenue increased from $30.37 billion to $34.26 billion.